These results clearly indicated that greater inhibition of cell viability and colony formation was obtained with N19 than with gefitinib in EGFR-mutated NSCLC cells and that this inhibition occurred via apoptosis. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.